Posts

Posted on

City Office REIT Announces Second Quarter 2025 Earnings Release and Conference Call

PR Newswire


VANCOUVER
, July 11, 2025 /PRNewswire/ — City Office REIT, Inc. (NYSE: CIO) (“City Office” or the “Company”) announced today it will release its financial results for the quarter ended June 30, 2025, before the market opens on Thursday, July 31, 2025.

City Office’s management will hold a conference call at 11:00 am Eastern Time on July 31, 2025 to discuss the Company’s financial results.  Additionally, a supplemental financial package to accompany the discussion of the results will be posted on www.cioreit.com.

Webcast

Click on the webcast link under the “Investor Relations” section of the Company’s website at www.cioreit.com.

Telephone Conference Call

Domestic: 1-833-470-1428
International: 1-404-975-4839
Passcode: 997238

Please dial in at least 10 minutes before the scheduled start time.

Conference Call Replay

Domestic: 1-866-813-9403
International: 1-929-458-6194
Passcode: 532319

A replay of the call will be available later in the day on July 31 2025, continuing through October 29, 2025.  A replay will also be available at “Webcasts & Events” in the “Investor Relations” section of the Company’s website.

About City Office REIT, Inc.

City Office REIT is an internally-managed real estate company focused on acquiring, owning and operating office properties located predominantly in Sun Belt markets. City Office currently owns or has a controlling interest in 5.4 million square feet of office properties. The Company has elected to be taxed as a real estate investment trust for U.S. federal income tax purposes.

Contact

City Office REIT, Inc.
Anthony Maretic, CFO
+1-604-806-3366
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/city-office-reit-announces-second-quarter-2025-earnings-release-and-conference-call-302502848.html

SOURCE City Office REIT, Inc.

Posted on

NFT Limited Announces Filing of the 2024 Annual Report on Form 20-F

Hong Kong, July 11, 2025 (GLOBE NEWSWIRE) — NFT Limited (“MI” or the “Company”) (NYSE: MI) today announced that on April 30, 2025, the Company filed its annual report on Form 20-F for the year ended December 31, 2024 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (the “SEC”).

In compliance with the New York Stock Exchange rules, the Form 20-F is available on the Company’s website at www.nftoeo.com. In addition, all shareholders of the Company may request, free of charge, a hard copy of the Company’s complete audited financial statements filed with the SEC. To request a hard copy of the Company’s audited financial statements, or for any other inquiry in respect of this press release, please contact the Investor Relations Department of the Company, whose contact information is as follows: [email protected]  


About NFT Limited

NFT Limited (formerly known as Takung Art Co Ltd.) operates an online electronic platform (www.nftoeo.com) for offering and trading of digital artwork. Through its platform, the Company allows artists/art dealers/owners to access a much bigger art trading market where they can engage with a wide range of investors. It generates revenue in the form of services in connection with the offering and trading of artwork on its platform, primarily consisting of listing fees, trading commissions, and management fees. Please visit: www.nftoeo.com.


Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Federal Securities Act, including but not limited to our expectations of future financial performance, business strategy or business. These statements constitute forecasts, prospects and forward-looking statements and are not performance guarantees. NFT warns that forward-looking statements are subject to many assumptions, risks and uncertainties that will change over time. Forward looking statements may be identified by words such as “may”, “can”, “should”, “will”, “estimate”, “plan”, “project”, “forecast”, “intend”, “expect”, “predict”, “believe”, “seek”, “target”, “Outlook” or similar words.

These forward-looking statements are based on information available as of the date of this press release and our management’s current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but not are limited to, the risk factors described by NFT in its filings with the Securities and Exchange Commission (“SEC”).


Contact


Investor Relations
[email protected]

SOURCE NFT Limited



Posted on

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., July 11, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on July 8, 2025, the compensation committee of the Company’s board of directors granted one new non-executive employee 4,600 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

About 4DMT

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery. 4D Molecular Therapeutics™, 4DMT™, Therapeutic Vector Evolution™, and the 4DMT logo are trademarks of 4DMT.

All of the Company’s product candidates are in clinical or preclinical development and have not yet been approved for marketing by the U.S. Food and Drug Administration or any other regulatory authority. No representation is made as to the safety or effectiveness of the Company’s product candidates for the therapeutic uses for which they are being studied.

Learn more at www.4DMT.com and follow us on LinkedIn.



Contacts:

Media:

Jenn Gordon
dna Communications
[email protected]

Investors:

Julian Pei
Head of Investor Relations and Corporate Finance
[email protected]

Posted on

Delisting of Securities from The Nasdaq Stock Market

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.’s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, rights, and units of Aquaron Acquisition Corp. Aquaron Acquisition Corp.’s securities were suspended on March 7, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, warrants, and rights of Bannix Acquisition Corp. Bannix Acquisition Corp.’s securities were suspended on March 17, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Avenue Therapeutics, Inc. Avenue Therapeutics, Inc.’s stock was suspended on March 19, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, warrants, units, and rights of WinVest Acquisition Corp. WinVest Acquisition Corp.’s securities were suspended on March 21, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, warrants, units, and rights of WinVest Acquisition Corp. WinVest Acquisition Corp.’s securities were suspended on March 21, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of IMAC Holdings, Inc. IMAC Holdings, Inc.’s stock was suspended on March 26, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of Lytus Technologies Holdings PTV Ltd. Lytus Technologies Holdings PTV. Ltd.’s commons shares were suspended on March 31, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Luokung Technology Corp. Luokung Technology Corp’s security was suspended on March 31, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of Aptose Biosciences, Inc. Aptose Biosciences, Inc.’s common shares were suspended on April 2, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.’s stock was suspended on April 4, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, units, and rights of ClimateRock. ClimateRock’s securities were suspended on April 10, 2025 and have not traded on Nasdaq since that time.

The Nasdaq Stock Market announced today that it will delist the common stock of Phoenix Motor Inc. Phoenix Motor Inc.’s stock was suspended on April 15, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, units, and rights of AI TRANSPORTATION ACQUISITION CORP. AI TRANSPORTATION ACQUISITION CORP’s securities were suspended on April 16, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and units of Denali Capital Acquisition Corp. Denali Capital Acquisition Corp.’s securities were suspended on April 16, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Thunder Power Holdings, Inc. Thunder Power Holdings, Inc.’s stock was suspended on April 22, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Charles & Colvard Ltd. Charles & Colvard Ltd.’s stock was suspended on April 25, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, rights, units, and warrants of Yotta Acquisition Corporation. Yotta Acquisition Corporation’s securities were suspended on April 28, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrants of Heramba Electric plc. Heramba Electric plc’s securities were suspended on April 29, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A Common Stock of Cumulus Media Inc. Cumulus Media Inc.’s stock was suspended on May 2, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants, units, and subunits of Aimfinity Investment Corp I. Aimfinity Investment Corp. I’s securities were suspended on May 5, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares of Starbox Group Holdings Ltd. Starbox Group Holdings Ltd.’s Class A ordinary shares were suspended on May 5, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Zoomcar Holdings, Inc. Zoomcar Holdings, Inc.’s securities were suspended on May 8, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ConnectM Technology Solutions, Inc. ConnectM Technology Solutions, Inc.’s stock was suspended on May 8, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and units of Investcorp AI Acquisition Corp. Investcorp AI Acquisition Corp.’s securities were suspended on May 8, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A ordinary shares, warrants, and units of Cartesian Growth Corporation II. Cartesian Growth Corporation II’s securities were suspended on May 13, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.’s stock was suspended on May 13, 2025 and has not traded on Nasdaq since that time

Nasdaq also announced today that it will delist the common stock of Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc.’s stock was suspended on May 15, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Affimed NV. Affimed N.V.’s stock was suspended on May 20, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of AppTech Payments Corp. AppTech Payments Corp.’s securities were suspended on May 20, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Damon Inc. Damon Inc.’s stock was suspended on May 20, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares and warrants of Zapp Electric Vehicles Group Limited. Zapp Electric Vehicles Group Limited’s securities were suspended on May 20, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares and warrants of LeddarTech Holdings Inc. LeddarTech Holdings Inc.’s securities were suspended on June 20, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Marin Software Incorporated. Marin Software Incorporated’s stock was suspended on June 26, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Marin Software Incorporated. Marin Software Incorporated’s stock was suspended on June 26, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Hall of Fame Resort & Entertainment Company. Hall of Fame Resort & Entertainment Company’s securities were suspended on June 27, 2025 and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.



Posted on

AMERISAFE Named to Ward’s Property-Casualty Top Performers List for 17th Consecutive Year

AMERISAFE Named to Ward’s Property-Casualty Top Performers List for 17th Consecutive Year

DERIDDER, La.–(BUSINESS WIRE)–
AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers’ compensation insurance focused on high-hazard industries, today announced the Company has been named to the Ward’s 50 top-performing property-casualty companies for the 17th consecutive year. This year’s award honors exceptional financial achievements in safety, consistency, and performance over the five-year period from 2020-2024.

Janelle Frost, President and CEO, said, “We are proud to be once again recognized among Ward’s Top 50 P&C insurers. This distinction reflects the strength and consistency of our operations. I am deeply grateful to our employees, whose dedication and expertise continues to drive our success.”

About AMERISAFE

AMERISAFE, Inc. is a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, and manufacturing. AMERISAFE actively markets workers’ compensation insurance in 27 states.

Andy Omiridis, EVP & CFO

AMERISAFE

337.463.9052

KEYWORDS: United States North America Louisiana

INDUSTRY KEYWORDS: Professional Services Insurance Human Resources

MEDIA:

Logo
Logo
Posted on

Mesabi Trust Press Release

Mesabi Trust Press Release

Announcement of Mesabi Trust Distribution

NEW YORK–(BUSINESS WIRE)–
The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of twelve cents ($0.12) per Unit of Beneficial Interest payable on August 20, 2025 to Mesabi Trust Unitholders of record at the close of business on July 30, 2025. This compares to a thirty cents ($0.30) per Unit distribution declared for the same period last year.

The Trustees’ announcement today of a twelve cents ($0.12) per Unit distribution, as compared to the thirty cents ($0.30) per Unit distribution announced by the Trust at the same time last year, reflects consideration of a number of factors. In particular, the Trustees’ current distribution determination reflects that the Trust’s receipt of total royalty payments of $2,422,329 on April 30, 2025, from Cleveland-Cliffs Inc. (“Cliffs”), the parent company of Northshore Mining Company (“Northshore”), was lower than the total royalty payments of $5,059,648 received by the Trust from Cliffs in April 2024.

The Trustees’ distribution announcement today also takes into account numerous other factors, including uncertainties resulting from Cliffs’ prior announcements regarding its vertical supply chain planning, the current volatility in the iron ore and steel industries generally, national and global economic uncertainties, potential changes in trade laws, the volume of unfairly traded imports, the imposition of new or termination of international duties or tariffs and ongoing disturbances from global unrest.

The Trustees have received no specific updates on Cliffs’ plans for the current year concerning Northshore iron ore operations or Northshore’s production, sale or shipments of iron ore products.

Quarterly royalty payments from Cliffs and Northshore for iron ore production and shipments during the first calendar quarter, which are payable to Mesabi Trust under the royalty agreement, are due July 30, 2025, together with the quarterly royalty report. After receiving the quarterly royalty report and payment, Mesabi Trust plans to file a summary of the quarterly royalty report with the Securities and Exchange Commission in a Current Report on Form 8-K.

Forward-Looking Statements

This press release contains certain forward-looking statements with respect to Northshore operations and Cliffs during 2025 and other matters, which statements are intended to be made under the safe harbor protections of the Private Securities Litigation Reform Act of 1995, as amended. Actual production, prices, price adjustments, sales and shipments of iron ore pellets, as well as actual royalty payments (including bonus royalties) could differ materially from current expectations due to inherent risks and uncertainties such as general adverse business and industry economic trends, uncertainties arising from war, terrorist events, imposition or termination of duties or tariffs and retaliatory tariffs, and other global events, higher or lower customer demand for steel and iron ore, decisions by mine operators regarding curtailments or idling production lines or entire plants, environmental compliance uncertainties, difficulties in obtaining and renewing necessary operating permits, higher imports of steel and iron ore substitutes, processing difficulties, consolidation and restructuring in the domestic steel market and other factors. Further, historically some of the royalties earned by Mesabi Trust have been based on estimated prices that are subject to interim and final adjustments, which can be positive or negative, and may be dependent in part on multiple price and inflation index factors under agreements to which Mesabi Trust was not a party and that were not known until after the end of a contract year. Although the Mesabi Trustees believe that any such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties, which could cause actual results to differ materially. Additional information concerning these and other risks and uncertainties is contained under the caption “Risk Factors” in Mesabi Trust’s filings with the Securities and Exchange Commission. Mesabi Trust undertakes no obligation to publicly update or revise any of the forward-looking statements made herein to reflect events or circumstances after the date hereof.

163598191.4

Mesabi Trust SHR Unit

Deutsche Bank Trust Company Americas

904-271-2520

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Professional Services Mining/Minerals Manufacturing Finance Natural Resources Steel

MEDIA:

Posted on

Fastenal Company Announces Cash Dividend

Fastenal Company Announces Cash Dividend

WINONA, Minn.–(BUSINESS WIRE)–
Fastenal Company (Nasdaq:FAST) (‘Fastenal’, ‘we’, ‘our’, or ‘us’) reported its board of directors declared a dividend of $0.22 per share to be paid in cash on August 26, 2025 to shareholders of record at the close of business on July 29, 2025. Except for share and per share information, dollar amounts are stated in millions. Share and per share information in this release has been adjusted to reflect a previously announced two-for-one stock split which took effect at the close of business on May 21, 2025.

We began paying annual dividends in 1991, semi-annual dividends in 2003, and then expanded to quarterly dividends in 2011. In addition to these regular dividend payments, we have previously paid special one-time dividends in December 2008, December 2012, December 2020, and December 2023. Our board of directors currently intends to continue paying quarterly dividends, though all future determinations as to payment of dividends will depend upon the financial condition and results of operations of Fastenal and such other factors as are deemed relevant by the board of directors at that time.

In 2025, 2024, and 2023, we paid (or declared) dividends as follows:

Year

 

First

Quarter

 

Second

Quarter

 

Third

Quarter

 

Fourth

Quarter

 

Sub-Total

(Regular)

Fourth

Quarter

(Special)

 

Total

2025

 

$

0.215

 

$

0.220

 

$

0.220

 

 

 

 

 

 

 

2024

 

$

0.195

 

$

0.195

 

$

0.195

 

$

0.195

 

$

0.780

$

—

 

$

0.780

2023

 

$

0.175

 

$

0.175

 

$

0.175

 

$

0.175

 

$

0.700

$

0.190

 

$

0.890

Dividend and common stock repurchase activity during the last ten years is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Per

 

 

Total

Dividends per Share

Total Value of

Total Number

Share Price of

 

Dividend

Dividends

Regular

 

Special

 

Total

 

Common Stock

of Shares

Common Stock

Year

Payments

Paid

Dividend

 

Dividend

 

Dividend

 

Purchased

Purchased

Purchased

2025

Three (1)

 

$

751.5

 

 

$

0.655

 

 

$

—

 

$

0.655

 

 

$

—

 

 

—

 

 

$

—

 

2024

Four

 

$

893.3

 

 

$

0.780

 

 

$

—

 

$

0.780

 

 

$

—

 

 

—

 

 

$

—

 

2023

Five (2)

 

$

1,016.8

 

 

$

0.700

 

 

$

0.190

 

$

0.890

 

 

$

—

 

 

—

 

 

$

—

 

2022

Four

 

$

711.3

 

 

$

0.620

 

 

$

—

 

$

0.620

 

 

$

237.8

 

 

10,000,000

 

 

$

23.79

 

2021

Four

 

$

643.7

 

 

$

0.560

 

 

$

—

 

$

0.560

 

 

$

—

 

 

—

 

 

$

—

 

2020

Five (2)

 

$

803.4

 

 

$

0.500

 

 

$

0.200

 

$

0.700

 

 

$

52.0

 

 

3,200,000

 

 

$

16.27

 

2019

Four

 

$

498.6

 

 

$

0.435

 

 

$

—

 

$

0.435

 

 

$

—

 

 

—

 

 

$

—

 

2018

Four

 

$

441.9

 

 

$

0.385

 

 

$

—

 

$

0.385

 

 

$

103.0

 

 

8,000,000

 

 

$

12.88

 

2017

Four

 

$

369.1

 

 

$

0.320

 

 

$

—

 

$

0.320

 

 

$

82.6

 

 

7,600,000

 

 

$

10.86

 

2016

Four

 

$

346.6

 

 

$

0.300

 

 

$

—

 

$

0.300

 

 

$

59.5

 

 

6,400,000

 

 

$

9.29

 

Ten Year Total

 

 

$

6,476.2

 

 

$

5.255

 

 

$

0.390

 

$

5.645

 

 

$

534.9

 

 

35,200,000

 

 

$

15.20

 

(1)

The Total Dividends Paid amount includes the estimated impact from this announcement. The estimate is calculated using the 1,147.6 million shares outstanding at June 30, 2025.

(2)

There was a supplemental dividend paid in December 2020 and December 2023.

In the second quarter of 2025, we did not repurchase any shares of our common stock.

We have authority to purchase up to 12,400,000 shares of our common stock under the July 12, 2022 authorization. This authorization does not have an expiration date.

All share and per share information reflects the two-for-one stock split in each of 2019 and 2025.

About Fastenal

With more than 3,500 in-market locations spanning 25 countries, Fastenal supplies a broad offering of fasteners, safety products, metal cutting products, and other industrial supplies to customers engaged in manufacturing, construction, warehousing, wholesale, and state and local government. By investing in local experts and inventory, customer-facing technology, wide-ranging services, and best-in-class sourcing and logistics, we offer a unique combination of capabilities to help our customers reduce cost, risk, and scalability constraints in their global supply chains. This “high-touch, high-tech” approach is reflected in our tagline, Where Industry Meets Innovation™.

Additional information regarding Fastenal is available on our website at www.fastenal.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that are not historical in nature and that are intended to be, and are hereby identified as, “forward looking statements” as defined in the Private Securities Litigation Reform Act of 1995, including statements regarding expectations as to payment of a quarterly cash dividend and stock repurchase activity in the foreseeable future. Any future determination as to payment of dividends or stock repurchases will depend upon the financial condition and results of operations of Fastenal and such other factors as are deemed relevant by the board of directors. For example, a change in business needs including working capital and funding for acquisitions, or a change in income tax law relating to dividends or stock repurchases, could cause us to decide not to pay a dividend in the future or not to repurchase common stock pursuant to the existing share repurchase authorization. A discussion of other risks and uncertainties is included in our filings with the Securities and Exchange Commission, including our most recent annual report and subsequent quarterly reports. FAST-D

Dray Schreiber

Financial Reporting & Regulatory Compliance Manager

507.313.7324

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Machinery Machine Tools, Metalworking & Metallurgy Other Manufacturing Manufacturing

MEDIA:

Logo
Logo
Posted on

Columbia Sportswear Company to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Columbia Sportswear Company to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

PORTLAND, Ore.–(BUSINESS WIRE)–
Columbia Sportswear Company (Nasdaq: COLM) plans to release second quarter 2025 financial results at approximately 4:05 p.m. ET on Thursday, July 31, 2025.

At approximately 4:15 p.m. ET, a commentary by Jim Swanson, Executive Vice President and Chief Financial Officer, reviewing the company’s second quarter 2025 financial results will be furnished to the SEC on Form 8-K and published to the company’s website at https://investor.columbia.com/financial-results. Analysts and investors are encouraged to review this commentary prior to participating in a conference call hosted by senior management at 5:00 p.m. ET.

To listen to the conference call, please dial 888-506-0062. The call will also be webcast live on the Investor Relations section of the Company’s website at http://investor.columbia.com where it will remain available until approximately July 31, 2026.

Columbia Sportswear Company connects active people with their passions and is a global multi-brand leading innovator in outdoor, active and lifestyle products including apparel, footwear, accessories, and equipment. Founded in 1938 in Portland, Oregon, the company’s brands are today sold in more than 100 countries. In addition to the Columbia® brand, Columbia Sportswear Company also owns the Mountain Hard Wear®, SOREL®, and prAna® brands. To learn more, please visit the company’s websites at www.columbia.com, www.mountainhardwear.com, www.sorel.com, and www.prana.com.

Investor Relations Contact:

Andrew Burns, CFA

Vice President of Investor Relations and Strategic Planning

Columbia Sportswear Company

503-985-4112

[email protected]

KEYWORDS: United States North America Oregon

INDUSTRY KEYWORDS: Retail Footwear Specialty Fashion

MEDIA:

Posted on

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in July of an aggregate of 12,385 restricted stock units (RSUs) of the company’s common stock to 6 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company’s board of directors under the Evolus’ 2023 Inducement Incentive Plan, with a grant date and vesting commencement date of July 7, 2025, as an inducement material to the new employees entering into employment with Evolus in accordance with Nasdaq Listing Rule 5635(c)(4).

The RSUs vest 25% on each annual anniversary of the vesting commencement date. The awards are subject to the terms and conditions of the 2023 Inducement Incentive Plan and the terms and conditions of the stock option agreement or RSU agreement, as applicable, covering the grant, including requirements to remain continuously employed on each vesting date.

About Evolus, Inc.

Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse™, a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.

Jeuveau® is a registered trademark and Evolysse™ is a trademark of Evolus, Inc.

Evolus Contacts:

Investors:

Nareg Sagherian

Vice President, Head of Global Investor Relations and Corporate Communications

Tel: 248-202-9267

Email: [email protected]

Media:

Email: [email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Medical Devices Surgery Women Biotechnology General Health Pharmaceutical Consumer Health Cosmetics Retail

MEDIA:

Logo
Logo
Posted on

Ingredion to Release 2025 Second Quarter Financial Results On August 1, 2025

WESTCHESTER, Ill., July 11, 2025 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its second quarter 2025 financial results for the period ended June 30, 2025, before the market opens Friday, August 1, 2025.

Jim Zallie, president and chief executive officer and Jim Gray, executive vice president and chief financial officer, will host a conference call August 1 at 8 a.m. CT to discuss the Company’s financial performance. The conference call and accompanying slide presentation will be webcast live at https://ir.ingredionincorporated.com/events-and-presentations. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the presentation. A replay of the presentation will be available on the Company’s website.

ABOUT THE COMPANY

Ingredion Incorporated (NYSE: INGR) headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2024 annual net sales of approximately $7.4 billion, the company turns grains, fruits, vegetables, and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion’s Idea Labs® innovation centers around the world and more than 11,000 employees, the company co-creates with customers and fulfills its purpose of bringing the potential of people, nature, and technology together to make life better. Visit ingredion.com for more information and the latest company news.

CONTACTS

Investors: Noah Weiss, 773-896-5242
Media: Rick Wion, 708-209-6323